Showing 1 of total 1 results (show query)
merck
psm3mkv:Evaluate Partitioned Survival and State Transition Models
Fits and evaluates three-state partitioned survival analyses (PartSAs) and Markov models (clock forward or clock reset) to progression and overall survival data typically collected in oncology clinical trials. These model structures are typically considered in cost-effectiveness modeling in advanced/metastatic cancer indications. Muston (2024). "Informing structural assumptions for three state oncology cost-effectiveness models through model efficiency and fit". Applied Health Economics and Health Policy.
Maintained by Dominic Muston. Last updated 10 months ago.
10 stars 6.43 score 1 scripts